Of note, Zekavat et al. [25] classified the assessments of CHIP-PAD and CHIP pan-arterial atherosclerosis based on potential driver genes and certain mutations, centering on DNMT3A, TET2, ASXL1, JAK2, DDR gene, and mutations that disturb splicing-related factors. The gene discussed is DNMT3A; the disease is atherosclerosis.